Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status.
International journal of hematology | 2014-04-01 | PMID 24532437
Kawajiri Chika, Tanaka Hiroaki, Hashimoto Shinichiro and 8 more
Genes: ABL1, BCR
